Abstract
We describe two patients who developed respiratory syncytial virus (RSV) pneumonia after BMT. One died of RSV pneumonia after three courses of steroid pulse therapy. Surprisingly, RSV antigen was identified in the bronchoalveolar lavage fluid (BALF) obtained post mortem. Steroid pulse therapy might have suppressed anti-RSV immunity, leading to persistent RSV infection for more than 1 month. The other patient received donor lymphocyte infusions (DLI) for relapsed plasma cell leukemia, while having active RSV pneumonia. His respiratory condition improved after DLI, and RSV antigen disappeared in BALF and nasal swabs. DLI might be effective in cases of life-threatening RSV pneumonia. Bone Marrow Transplantation (2000) 26, 573–576.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McCarthy AJ, Kingman HM, Kelly C et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation Bone Marrow Transplant 1999 24: 1315–1322
Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients Clin Infect Dis 1996 22: 778–782
Subbarao EK, Dietrich MC, De Sierra TM et al. Rapid detection of respiratory syncytial virus by a biotin-enhanced immunoassay: test performance by laboratory technologists and housestaff Pediatr Infect Dis J 1989 8: 865–869
Freymuth F, Eugene G, Vabret A et al. Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with a DNA enzyme immunoassay J Clin Microbiol 1995 33: 3352–3355
Whimbey E, Champlin RE, Englund JA et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients Bone Marrow Transplant 1995 16: 393–399
Englund JA, Sullivan CJ, Jordan MC et al. Respiratory syncytial virus infection in immunocompromised adults Ann Intern Med 1988 109: 203–208
Lewinsohn DM, Bowden RA, Mattson D, Crawford SW . Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation Antimicrob Agents Chemother 1996 40: 2555–2557
Bowden RA . Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience Am J Med 1997 102: (3A) 27–30
Alwan WH, Record FM, Openshaw PJ . CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells Clin Exp Immunol 1992 88: 527–536
van Woensel JB, Wolfs TF, van Aalderen WM et al. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis Thorax 1997 52: 634–637
Bulow SM, Nir M, Levin E et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants Pediatrics 1999 104: 77
Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusions of donor leukocytes to treat Epstein–Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation New Engl J Med 1994 330: 1185–1191
Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation (letter) Blood 1994 84: 1689–1690
Ilan Y, Nagler A, Shouval D et al. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors Clin Exp Immunol 1994 97: 299–302
Ilan Y, Nagler A, Adler R et al. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor Gastroenterology 1993 104: 1818–1821
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kishi, Y., Kami, M., Oki, Y. et al. Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation. Bone Marrow Transplant 26, 573–576 (2000). https://doi.org/10.1038/sj.bmt.1702559
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702559
Keywords
This article is cited by
-
Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients
Bone Marrow Transplantation (2015)
-
A Prospective Surveillance of Nosocomial Respiratory Syncytial Virus Infection in a Hematology Ward: A Single-Center Experience in Japan
International Journal of Hematology (2001)